Anti-MDA5 antibodies (36.3%) were the most common specific autoantibodies in CADM, followed by anti-Jo-1, anti-PL-7, anti-EJ, and anti-PL-12, which is similar to that observed in the CADM-ILD cohort reported by Wu et al. This evidence concerns the gene IFIH1 and clinically amyopathic dermatomyositis.